Craft

Heron Therapeutics

Stock Price

$1.8

2024-10-29

Market Capitalization

$268.5 M

2024-10-29

Revenue

$154.9 M

FY, 2025

Heron Therapeutics Summary

Company Summary

Overview
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. It uses a Biochronomer polymer-based drug delivery platform designed to manage the therapeutic profile of injectable pharmaceuticals.
Type
Public
Status
Active
Founded
1983
HQ
San Diego, CA, US | view all locations
Website
https://www.herontx.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Ira Duarte

    Ira Duarte, Executive Vice President, Chief Financial Officer

  • Lisa Peraza, Vice President, Chief Accounting Officer

  • John Arthur

    John Arthur, Vice President, Manufacturing & Supply

  • Sean Ristine

    Sean Ristine, Senior Vice President, Human Resources

LocationsView all

1 location detected

  • San Diego, CA HQ

    United States

    4242 Campus Point Ct #200

Heron Therapeutics Financials

Summary Financials

Revenue (Q1, 2026)
$34.7M
Gross profit (Q1, 2026)
$24.1M
Net income (Q1, 2026)
($8.1M)
Cash (Q1, 2026)
$26.1M
EBIT (Q1, 2026)
($4.8M)
Enterprise value
$275.7M

Footer menu